1992
DOI: 10.1136/bmj.304.6832.983-c
|View full text |Cite
|
Sign up to set email alerts
|

Screening for cervical cancer in developing countries.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1995
1995
2008
2008

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…The recommended 3‐dose course costs approximately US $360 (MYR 1200) and is unaffordable for many, especially women of lower socioeconomic status. These women have the highest risk of cervical cancer but often lack access to preventive care such as cervical screening [19]. To ensure wide coverage, the vaccine may need to be subsidized or incorporated into the vaccination program in Malaysia [20].…”
Section: Discussionmentioning
confidence: 99%
“…The recommended 3‐dose course costs approximately US $360 (MYR 1200) and is unaffordable for many, especially women of lower socioeconomic status. These women have the highest risk of cervical cancer but often lack access to preventive care such as cervical screening [19]. To ensure wide coverage, the vaccine may need to be subsidized or incorporated into the vaccination program in Malaysia [20].…”
Section: Discussionmentioning
confidence: 99%
“…The risk of developing CC increases with early start of sexual activity, number of sexual partners, prolonged use of oral contraceptives and smoking [ 4 ]. In Mexico it is associated with poverty related factors such as low schooling, unemployment, residence in rural areas and lack of access to health services [ 5 - 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, while these methods may prove feasible in a developed country's national screening program, they remain highly laboratory‐dependent and are not yet applicable in most developing countries. Direct visual inspection and immediate referral for treatment is another approach that is less laboratory‐dependent19 but requires new training of clinical staff 20–22. Thus, technical, financial and personnel constraints provide formidable challenges to implementing effective national CC screening programs in many developing countries in the near future.…”
mentioning
confidence: 99%